Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
What is Cancer?02:12

What is Cancer?

15.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
15.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The meaning of "p-value": Pursuing clinical and statistical significance. A narrative review.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2026
Same author

Laparoscopic retroperitoneal lymph node dissection in testicular cancer: feasibility and safety at a tertiary center.

Cirugia y cirujanos·2026
Same author

[Sensitivity and validity of sentinel node biopsy in early-stage cervical cancer at an oncology institution].

Cirugia y cirujanos·2026
Same author

Beyond individual markers: Prognostic value of the combined CEA/PNI score in metastatic colorectal cancer as a predictor of survival.

PloS one·2026
Same author

Long‑term outcomes of prophylactic cranial irradiation in high‑risk metastatic NSCLC: Final PRoT‑BM analysis.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Impact of germline genetic variation on breast cancer prognosis: a systematic review and meta-analysis.

BMC cancer·2026

Related Experiment Video

Updated: Mar 15, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K

Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico.

Nancy Reynoso-Noverón, Abelardo Meneses-García, Aura Erazo-Valle

    Salud Publica De Mexico
    |August 25, 2016
    PubMed
    Summary

    Mexico lacks a national cancer control policy despite cancer being a leading cause of death. This paper proposes a comprehensive National Program for Cancer Control to reduce incidence, improve survival, and enhance patient quality of life.

    More Related Videos

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
    06:42

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

    Published on: September 2, 2025

    702
    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    988

    Related Experiment Videos

    Last Updated: Mar 15, 2026

    Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
    09:29

    Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

    Published on: September 30, 2016

    14.5K
    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
    06:42

    Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications

    Published on: September 2, 2025

    702
    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
    06:46

    Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

    Published on: September 27, 2024

    988

    Area of Science:

    • Oncology
    • Public Health
    • Health Policy

    Background:

    • Chronic noncommunicable diseases (NCDs), particularly cancer, are a major global health burden.
    • Cancer is the third leading cause of death in Mexico, disproportionately affecting the working population with late-stage diagnoses and limited healthcare access.
    • Currently, Mexico lacks a dedicated public policy for cancer management.

    Purpose of the Study:

    • To present the first interinstitutional proposal for a National Program for Cancer Control in Mexico.
    • To address critical aspects of cancer management, including risk factors, early detection, treatment, palliative care, and rehabilitation.
    • To identify challenges and needs within the Mexican health system for effective cancer control.

    Main Methods:

    • Development of an interinstitutional proposal for a National Program for Cancer Control.
    • Consideration of established cancer risk factors, screening, treatment modalities, and supportive care.
    • Analysis of the Mexican health system's capacity and requirements for program implementation.

    Main Results:

    • A detailed proposal for a National Program for Cancer Control has been formulated.
    • The program integrates a continuum of care from prevention to rehabilitation.
    • Key challenges and essential needs for the Mexican health system are outlined.

    Conclusions:

    • A comprehensive, interinstitutional National Program for Cancer Control is essential for Mexico.
    • Addressing risk factors, early detection, and patient care is crucial to reduce cancer burden.
    • Successful implementation requires addressing systemic difficulties and meeting identified needs to improve cancer outcomes.